About SFN (The Illness Info)

What is Small Fiber Neuropathy (SFN)?

Small Fiber Neuropathy (SFN) is a neurological condition caused by widespread structural damage to the smallest nerve endings in the peripheral nervous system. These tiny unmyelinated C-fibers and thinly myelinated A-delta fibers are responsible for two major bodily functions:

  1. Somatic Sensation: Relaying signals for chronic burning pain, freezing cold, stabbing, and changes in temperature to the brain.
  2. Autonomic Control: Regulating automatic involuntary bodily actions like heart rate, blood pressure stability, gastrointestinal motility, and internal sweating mechanisms.

When these microscopic fibers are destroyed, normal communication breaks down. Living with untreated Small Fiber Neuropathy can be absolute torture. Understanding why your nerves are misfiring or dying is the critical first step to accessing targeted medical treatment in the UK.

Comprehensive Checklist of SFN Causes

Small fiber neuropathy is rarely, some would argue never, a standalone condition; it is almost always a structural symptom triggered by an underlying systemic illness, viral invasion, metabolic toxicity, or genetic mutation. If your neurologist tells you you’re ‘Idiopathic’ we believe it just means they haven’t done enough tests to find the cure.

If you are currently undergoing a diagnostic screening with a UK GP or Neurologist, ensure they systematically check for the following causes:

🧬 1. Autoimmune & Connective Tissue Conditions

When the immune system malfunctions, it can produce autoantibodies that directly target and dismantle the peripheral nervous system: [1]

  • Sjögren’s Syndrome: One of the most prevalent autoimmune drivers of pure SFN, frequently presenting alongside severe dry eyes, dry mouth, or joint discomfort.
  • Systemic Lupus Erythematosus (SLE): Chronic widespread tissue and vascular inflammation that alters small nerve density.
  • Sarcoidosis: An inflammatory condition causing micro-granulomas to assemble around and strangle fine nerve pathways.
  • Coeliac Disease: Severe gluten-sensitive systemic immune reactions that compromise peripheral nerve stability, independent of intestinal symptoms.
  • Other Systemic Autoimmune Conditions: Rheumatoid Arthritis, Hashimoto’s Thyroiditis, and mixed connective tissue diseases.
  • Connective Tissue Disorders / Hypermobility: Conditions like Ehlers-Danlos Syndrome (EDS). There is a massive, clinically documented statistical overlap connecting hypermobility, POTS, and systemic SFN.

🦠 2. Post-Viral & Post-Infection Syndromes

Infections can trigger a severe “hyper-inflammatory” cascade, causing the body to inadvertently attack small nerve endings long after the primary virus has cleared:

  • Post-COVID-19 Infection (Long COVID): A leading modern cause of sudden-onset, widespread small fiber neuropathy and dysautonomia.
  • COVID-19 Vaccination / Booster Actions: Documented in subsets of patients as a rare post-vaccination inflammatory or autoimmune nerve flare. This is not conspiracies, these are facts about some reactions to the Covid-19 vaccination.
  • Other Post-Viral Syndromes: Chronic post-viral damage triggered by the Epstein-Barr Virus (Glandular Fever), Chronic Fatigue Syndrome (ME/CFS), Severe Influenza, or HIV.

🧪 3. Blood, Metabolic, & Organ Dysfunctions

  • Monoclonal Gammopathy (MGUS): A critical blood condition involving abnormal paraproteins (paraproteinemia) in the bloodstream. It is a premier cause of SFN in older adults, and a standard Serum Protein Electrophoresis (SPEP) test is required to check for it.
  • Thyroid Dysfunction: Uncontrolled Hypothyroidism or Hyperthyroidism altering nerve metabolic cycles.
  • Renal or Liver Disease: Chronic kidney or liver impairment allowing toxic metabolic wastes to accumulate in the bloodstream, leading to progressive chemical nerve damage.

💊 4. Toxic Exposures & Nutritional Deficiencies

  • Fluoroquinolone Antibiotic Toxicity: Highly toxic “black box” reactions linked to prescription antibiotics such as Ciprofloxacin.
  • Chemotherapy and Medical Treatments: Highly neurotoxic cancer treatments (such as bortezomib or cisplatin) that destroy epidermal nerve fiber lines.
  • Vitamin Deficiencies & Toxicities: Severe Vitamin B12 deficiency (often linked to pernicious anaemia), Iron Deficiency/Anemia, Vitamin D deficiency, or excessive Vitamin B6 toxicity from over-supplementation. [1, 2, 3, 4, 5]

🧬 5. Genetic & Hereditary Factors

  • Sodium Channel Gene Mutations: Inherited structural variations in specific pain-regulating genes (such as SCN9A or SCN10A) that leave the nerve’s pain volume dial permanently stuck on “high”.
  • Rare Hereditary Diseases: Fabry Disease, Familial Amyloidosis, or Pompe Disease.

❓ 6. Idiopathic / Cryptogenic SFN

  • Unknown Origins: Up to 30% to 50% of small fiber neuropathy cases globally are classified as idiopathic or cryptogenic. This simply means that despite extensive modern testing, doctors have not yet identified the specific trigger.

    Many idiopathic cases are increasingly suspected to be hidden, localized autoimmune reactions or conditions that haven’t yet been tested for by your Dr. We would recommend continuing with novel antibody tests until you get a marker showing immune dysfunction, which is likely.

🧬 Immune-Mediated SFN: The Specific Autoantibodies

If standard screening panels return clean but your SFN symptoms continue to worsen, your nerve damage may be actively driven by a localized autoimmune process. Research from institutions like Washington University in St. Louis has identified specialized neuro-targeting autoantibodies present in individuals previously labeled as “idiopathic”.

If you are pursuing an Autoimmune Neuropathy Panel, ensure your specialists look closely for these specific markers:

  • TS-HDS (Trisulfated Heparan Disaccharide) IgM: This antibody mistakenly targets a specific carbohydrate molecule highly concentrated on the surface of small, sensory nerve fibers. High titers of TS-HDS are closely linked to non-length-dependent, sudden-onset burning pain and small-vessel vasculitis in the skin.
  • FGFR3 (Fibroblast Growth Factor Receptor 3) IgG: Targets an essential structural receptor protein found on sensory neurons inside the dorsal root ganglia. FGFR3 autoantibodies are a major marker for painful progressive sensory small-fiber neuropathy.
  • Plexin D1 IgG: A modern biomarker linked directly to severe burning pain, hypersensitivity to touch (allodynia), and extreme temperature hyperalgesia.
  • Caspr2 (Contactin-Associated Protein-Like 2): An antibody targeting voltage-gated potassium channel complexes, highly correlated with severe neuropathic twitching, burning pain flares, and autonomic instability.
  • MX1 (Myxovirus Resistance Protein 1): A novel biomarker currently being mapped that selectively binds to small sensory neurons, indicating active immune-mediated attack lines.

👁️ Sjögren’s Syndrome Specific Antibodies

Sjögren’s Syndrome is notoriously underdiagnosed because it can present as a “neuropathy-first” or “seronegative” condition. This means you can have severe nerve damage from Sjögren’s long before you develop the classic symptoms of dry eyes or a dry mouth.

If your neurologist or rheumatologist is checking for an underlying Sjögren’s trigger, they must run a comprehensive autoantibody panel containing these markers:

  • Anti-SSA (Ro) / Ro52 & Ro60: The most common diagnostic antibodies checked for Sjögren’s. They target specific ribonucleoprotein complexes in cellular bodies. However, a significant portion of patients with small fiber neuropathy driven by Sjögren’s will actually test negative for standard Anti-SSA, which is why deeper testing is vital.
  • Anti-SSB (La): Frequently checked alongside Anti-SSA. It is another traditional biomarker that confirms systemic Sjögren’s activity, though it is less commonly found in pure, isolated neurological presentations.
  • Early Sjögren’s Biomarkers (SP-1, CA-6, PSP): This is a specialized, advanced panel (often called the Lipcoals or Early Sjögren’s panel). It tests for Salivary Gland Protein 1 (SP-1), Carbonic Anhydrase 6 (CA-6), and Parotid Secretory Protein (PSP). These antibodies show up much earlier in the disease cycle than traditional SSA/SSB markers, making them crucial for identifying hidden Sjögren’s in “seronegative” SFN patients.
  • Rheumatoid Factor (RF) & Antinuclear Antibodies (ANA): General, non-specific inflammatory blood markers. While they don’t explicitly diagnose Sjögren’s on their own, high titers strongly indicate an active, systemic connective tissue or autoimmune assault that warrants a lip biopsy or a referral to a specialist rheumatologist.

⚠️ Note on Label Verification & Medical Guidance

Please remember that this information is provided for general educational purposes to assist in your advocacy [Health]. Always explicitly double-check your physical laboratory forms, printouts, reference ranges, and test names to verify your details are entirely accurate before presenting data to your medical team [Health]. SFN presentation varies wildly, and an accurate differential workup requires direct evaluation by a qualified UK Neurologist [Health].